National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 2949-2950 [2023-00743]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty
International Center Advisory Board.
Date: February 6–7, 2023.
Closed: February 6, 2023, 1:00 p.m. to
4:00 p.m.
Agenda: To review and evaluate the
second level of grant applications.
Place: Fogarty International Center,
National Institutes of Health, Lawton
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892.
Open: February 7, 2023, 9:00 a.m. to
3:00 p.m.
Agenda: Update and discussion of
current and planned Fogarty
International Center activities.
Place: Fogarty International Center,
National Institutes of Health, Lawton
Chiles International House (Stone
House), 16 Center Drive, Conference
Room, Bethesda, MD 20892 (Virtual
Meeting).
Meeting Access: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx.
Contact Person: Kristen Weymouth,
Executive Secretary, Fogarty
International Center, National Institutes
of Health, 31 Center Drive, Room
B2C02, Bethesda, MD 20892, 301–496–
1415, kristen.weymouth@nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Additional Health and Safety
Guidance: Before attending a meeting at
an NIH facility, it is important that
visitors review the NIH COVID–19
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
Safety Plan at https://ors.od.nih.gov/sr/
dohs/safety/NIH-covid-19-safety-plan/
Pages/default.aspx for information
about requirements and procedures for
entering NIH facilities, especially when
COVID–19 community levels are
medium or high. In addition, the Safer
Federal Workforce website has FAQs for
visitors at https://www.saferfederal
workforce.gov/faq/visitors/. Please note
that if an individual has a COVID–19
diagnosis within 10 days of the meeting,
that person must attend virtually. (For
more information please read NIH’s
Requirements for Persons after Exposure
at https://ors.od.nih.gov/sr/dohs/safety/
NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/persons-afterexposure.aspx and What Happens When
Someone Tests Positive at https://
ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.
aspx.) Anyone from the public can
attend the open portion of the meeting
virtually via the NIH Videocasting
website (https://videocast.nih.gov).
Please continue checking these
websites, in addition to the committee
website listed below, for the most up to
date guidance as the meeting date
approaches.
Information is also available on the
Institute’s/Center’s home page: https://
www.fic.nih.gov/About/Advisory/Pages/
default.aspx, where an agenda and any
additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
in Acquired Immunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Dated: January 11, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00765 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
2949
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
Mechanistic Ancillary Studies Review
Meeting.
Date: February 27, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
AMS Member Conflict Review Meeting.
Date: February 27, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bernard Joseph
Dardzinski, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
of Arthritis, Musculoskeletal and Skin
Diseases, NIH, 6701 Democracy Boulevard.,
Room 824, Plaza One, Bethesda, MD 20817,
301–435–1146, bernard.dardzinski@nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
AMSC Member Conflict Review Meeting.
Date: March 8, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 800,
Bethesda, MD 20892, 301–594–4952, linh1@
mail.nih.gov.
E:\FR\FM\18JAN1.SGM
18JAN1
2950
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
P30 Rheumatic Diseases Research ResourceBased Centers Review Meeting.
Date: March 9–10, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 820, Bethesda,
MD 20892, 301–827–7835,
yasuko.furumoto@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: January 11, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00743 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Allergy and Asthma
Statistical and Clinical Coordinating Center
(AA–SCCC) (U01 Clinical Trial Not Allowed)
Date: February 13, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G72,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Lindsey M. Pujanandez,
Ph.D., Scientific Review Officer, Scientific
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G72,
Rockville, MD 20852, (240) 627–3206,
lindsey.pujanandez@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: January 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00866 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Integrative Myocardial Physiology/
Pathophysiology B Study Section.
Date: February 14–15, 2023.
Time: 8:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Kirk E. Dineley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 806E,
Bethesda, MD 20892, (301) 867–5309,
dineleyke@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Viral Pathogenesis and Immunity Study
Section.
Date: February 14–15, 2023.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00074
Fmt 4703
Sfmt 9990
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301)435–
1742, kaushikbasun@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurodifferentiation,
Plasticity, Regeneration and Rhythmicity
Study Section.
Date: February 14–15, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 594–7574,
topczewskij2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Skeletal Muscle and Exercise
Physiology
Date: February 14, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Bertoni, Ph.D.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805B
Bethesda, MD 20892 (301) 867–5309
bertonic2@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Development—1
Study Section.
Date: February 14, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zubaida Saifudeen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 827–3029, zubaida.saifudeen@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 11, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00754 Filed 1–17–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Pages 2949-2950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00743]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS
Mechanistic Ancillary Studies Review Meeting.
Date: February 27, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard,
Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS AMS
Member Conflict Review Meeting.
Date: February 27, 2023.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Bernard Joseph Dardzinski, Ph.D., Scientific
Review Officer, Scientific Review Branch, National Institute of
Arthritis, Musculoskeletal and Skin Diseases, NIH, 6701 Democracy
Boulevard., Room 824, Plaza One, Bethesda, MD 20817, 301-435-1146,
[email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS AMSC
Member Conflict Review Meeting.
Date: March 8, 2023.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Helen Lin, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard,
Suite 800, Bethesda, MD 20892, 301-594-4952, [email protected].
[[Page 2950]]
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS P30
Rheumatic Diseases Research Resource-Based Centers Review Meeting.
Date: March 9-10, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
820, Bethesda, MD 20892, 301-827-7835, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: January 11, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-00743 Filed 1-17-23; 8:45 am]
BILLING CODE 4140-01-P
